MXCT
MaxCyte, Inc. · Healthcare
EVP, Global Sales Thomas M. Ross sold $148K of MaxCyte, Inc.
Sold$148,135
$4.44Price
33,333Shares
−57%Stake
What MXCT did after the filing
- The stock from Mon, Aug 5 close, $4.34
- −5.5%
- S&P 500, same days
- +8.8%
Measured over 30 trading days, to the Sep 17 close.
Traded Thu, Aug 1. Filed Mon, Aug 5, 2:57 PM ET, during the session. Returns use the Aug 5 close and the Sep 17 close. Not investment advice.